STOCK TITAN

Ubie and CMI Media Group Partner to Modernize DTC Advertising with Highly Personalized Consumer Campaigns in Women's Health, Hematology

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags
partnership

Ubie and CMI Media Group, a WPP company, have announced a strategic partnership to revolutionize direct-to-consumer (DTC) advertising in healthcare, initially focusing on women's health and hematology/oncology. The collaboration combines Ubie's AI-driven healthcare prediction platform with CMI's media expertise to deliver personalized healthcare information to patients.

The partnership aims to address key healthcare challenges including long wait times, rising costs, and information overload. Ubie's platform offers a free, medically-validated AI symptom checker that helps guide patients to appropriate medical care. The initiative will particularly focus on endometriosis and hematology, areas where patients actively seek reliable information.

Ubie e CMI Media Group, una società del gruppo WPP, hanno annunciato una partnership strategica per rivoluzionare la pubblicità direct-to-consumer (DTC) nel settore sanitario, con un focus iniziale sulla salute femminile e l'ematologia/oncologia. La collaborazione unisce la piattaforma predittiva sanitaria basata su intelligenza artificiale di Ubie con l'esperienza media di CMI per fornire informazioni sanitarie personalizzate ai pazienti.

L’obiettivo della partnership è affrontare le principali sfide sanitarie, tra cui lunghi tempi di attesa, costi in aumento e sovraccarico di informazioni. La piattaforma di Ubie offre un controllo gratuito dei sintomi, validato medicalmente e basato su AI, che guida i pazienti verso le cure mediche più appropriate. L’iniziativa si concentrerà in particolare su endometriosi ed ematologia, ambiti in cui i pazienti cercano attivamente informazioni affidabili.

Ubie y CMI Media Group, una empresa del grupo WPP, han anunciado una alianza estratégica para revolucionar la publicidad directa al consumidor (DTC) en el sector salud, enfocándose inicialmente en la salud femenina y hematología/oncología. La colaboración combina la plataforma de predicción sanitaria impulsada por IA de Ubie con la experiencia en medios de CMI para ofrecer información sanitaria personalizada a los pacientes.

La alianza busca abordar desafíos clave en salud, como largos tiempos de espera, costos crecientes y sobrecarga de información. La plataforma de Ubie ofrece un verificador de síntomas gratuito, validado médicamente y basado en IA, que ayuda a guiar a los pacientes hacia la atención médica adecuada. La iniciativa se enfocará especialmente en endometriosis y hematología, áreas donde los pacientes buscan activamente información confiable.

UbieCMI Media Group(WPP 계열사)는 헬스케어 분야에서 직접 소비자 대상(DTC) 광고를 혁신하기 위한 전략적 파트너십을 발표했으며, 초기에는 여성 건강과 혈액학/종양학에 중점을 둡니다. 이번 협업은 Ubie의 AI 기반 헬스케어 예측 플랫폼과 CMI의 미디어 전문성을 결합하여 환자에게 맞춤형 건강 정보를 제공합니다.

이 파트너십은 긴 대기 시간, 비용 상승, 정보 과부하 등 주요 헬스케어 문제를 해결하는 것을 목표로 합니다. Ubie의 플랫폼은 무료이며 의학적으로 검증된 AI 증상 검사기를 제공해 환자가 적절한 의료 서비스를 받을 수 있도록 안내합니다. 이번 이니셔티브는 특히 환자들이 신뢰할 수 있는 정보를 적극적으로 찾는 자궁내막증과 혈액학 분야에 집중할 예정입니다.

Ubie et CMI Media Group, une société du groupe WPP, ont annoncé un partenariat stratégique visant à révolutionner la publicité directe aux consommateurs (DTC) dans le domaine de la santé, en se concentrant initialement sur la santé des femmes et l’hématologie/oncologie. Cette collaboration combine la plateforme prédictive de santé basée sur l’IA d’Ubie avec l’expertise média de CMI pour fournir des informations de santé personnalisées aux patients.

Le partenariat vise à relever les principaux défis du secteur de la santé, tels que les longs délais d’attente, l’augmentation des coûts et la surcharge d’informations. La plateforme d’Ubie propose un vérificateur de symptômes gratuit, validé médicalement et basé sur l’IA, qui aide à orienter les patients vers les soins médicaux appropriés. L’initiative se concentrera particulièrement sur l’endométriose et l’hématologie, des domaines où les patients recherchent activement des informations fiables.

Ubie und CMI Media Group, ein Unternehmen der WPP-Gruppe, haben eine strategische Partnerschaft angekündigt, um die Direkt-zu-Verbraucher (DTC) Werbung im Gesundheitswesen zu revolutionieren, mit anfänglichem Fokus auf Frauengesundheit sowie Hämatologie/Onkologie. Die Zusammenarbeit vereint Ubies KI-gestützte Gesundheitsvorhersageplattform mit CMIs Medienkompetenz, um personalisierte Gesundheitsinformationen für Patienten bereitzustellen.

Die Partnerschaft zielt darauf ab, zentrale Herausforderungen im Gesundheitswesen zu bewältigen, darunter lange Wartezeiten, steigende Kosten und Informationsüberflutung. Ubies Plattform bietet einen kostenlosen, medizinisch validierten KI-Symptomprüfer, der Patienten zur passenden medizinischen Versorgung führt. Der Schwerpunkt der Initiative liegt insbesondere auf Endometriose und Hämatologie, Bereiche, in denen Patienten aktiv nach verlässlichen Informationen suchen.

Positive
  • Partnership combines AI technology with precision media expertise to improve healthcare information delivery
  • Addresses critical market needs in women's health and hematology/oncology sectors
  • Potential to accelerate diagnosis and treatment identification through personalized approach
  • Free and accessible AI-powered symptom checker platform
Negative
  • None.

Insights

WPP's CMI partnership with Ubie brings AI-driven personalization to pharmaceutical advertising, potentially modernizing the lucrative DTC healthcare marketing landscape.

This partnership between WPP-owned CMI Media Group and AI healthcare platform Ubie represents a strategic pivot in how pharmaceutical direct-to-consumer advertising is executed. By combining Ubie's AI Symptom Checker with CMI's media expertise, WPP is positioning itself at the intersection of two high-value segments: healthcare advertising and AI-driven personalization.

The initial focus on endometriosis and hematology is particularly strategic. Women's health represents a $57 billion market globally with endometriosis affecting approximately 1 in 10 women of reproductive age, while hematology/oncology treatments command premium pricing and sustained marketing investment from pharmaceutical companies.

This approach addresses a critical industry challenge: the diminishing effectiveness of traditional broad-reach pharmaceutical advertising. By targeting consumers with symptoms that match specific conditions, the partnership could significantly improve conversion rates and ROI on pharmaceutical marketing spend – a key selling point for WPP's pharmaceutical clients who collectively spend billions annually on consumer marketing.

For WPP specifically, this represents an evolution of their healthcare marketing capabilities, integrating cutting-edge AI with their existing media expertise. In an advertising landscape increasingly dominated by personalization, this partnership potentially creates a differentiated service offering that could attract pharmaceutical clients looking for more efficient patient acquisition channels.

The timing aligns with growing healthcare consumerism and increasing patient self-advocacy, particularly in underserved therapeutic areas like women's health. By providing deeper engagement earlier in the patient journey, this model could reshape how pharmaceutical companies allocate their substantial marketing budgets – potentially favoring WPP's data-driven approach over traditional mass-media campaigns.

  • There is a critical need for trustworthy, hyper-personalized information earlier in the diagnosis and treatment journey to empower patients to participate in their care
  • The partnership will initially focus on endometriosis and hematology; high-need therapeutic areas where patients are actively seeking information
  • Connecting tailored information with relevant, motivated audiences will reinvent the way DTC advertising interacts and engages with consumers

NEW YORK, May 13, 2025 /PRNewswire/ -- Ubie, an AI-driven and medically vetted healthcare prediction platform that guides patients to the care they need, and CMI Media Group, a WPP (NYSE: WPP), healthcare media agency, announced a partnership aiming to transform direct-to-consumer (DTC) advertising, beginning with women's health and hematology/oncology. The collaboration integrates Ubie's AI Symptom Checker with CMI's precision media expertise to address the pharmaceutical industry's challenges in reaching patients with personalized, engaging messaging at scale. This combination will help accelerate time to diagnosis and the identification of the best available treatment.

American consumers continue to face challenges in managing their own health, including long waits for doctor appointments and treatment, increasing healthcare costs, and broken patient engagement. At the same time, consumers are more active in seeking information for their health conditions, increasingly relying on online tools and information. But, there is an excessive amount of noise online, including a large amount of conflicting information and misinformation.

To reach consumers, marketers need to meet patients where they are, by using highly-personalized, patient-centric, and brand-safe approaches, rather than the traditional scattergun approach – a concept understood in industries outside of healthcare.

"Today's healthcare consumers are active and want to be engaged with, but with so many websites, ads, and social media posts, it can be a struggle to understand what information to trust to take control of their own care," said Kota Kubo, Co-Founder and CEO of Ubie. "By combining the ability of Ubie's medically trained AI to decode symptom patterns with CMI's strategic expertise in reaching consumers, we're creating tools that can better connect with those looking for answers about their symptoms."

A one size fits all approach doesn't help patients navigate healthcare. Personalization is one key to delivering improved opportunities to engage in health behaviors. The partnership will allow DTC advertisers to engage patients individually, reaching consumers who are searching for more information where they are.

Ubie's online platform is a highly accurate, medically-validated AI symptom checker that is free and easily accessible. Ubie engages patients early in their journey, providing personalized information about potential conditions and guiding them toward appropriate medical care, including appropriate providers and treatment information. This information can empower patients to become knowledgeable, active participants in their own health care and take the steps needed for better outcomes.

"For this specific partnership, women's health was a perfect fit. The need for education in this space is at a critical place right now. By leveraging new technologies that allow women the opportunity to quickly and accurately gain access to data is life changing," adds Julie Hurvitz Aliaga, EVP of Innovation, Content and Partnerships of CMI Media Group.

Viewing people as consumers of healthcare, rather than passive receivers, can enhance the quality of care. New innovations, like AI trained on medical data, can reach consumers with individually tailored information. DTC advertising has the opportunity to meet even the most unique needs with resources that can empower consumers to become partners in their care.

About CMI Media Group  

CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a global, full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group's core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world's top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in inclusion, talent retention and employee development as well as one of the industry's best places to work. To apply for a position within our teams visit https://www.cmimediagroup.com/careers/

About Ubie

Founded in 2017, Ubie empowers individuals and healthcare professionals with the tools they need for better care. Leveraging cutting-edge disease prediction AI, Ubie guides 10+ million patients every month to seek appropriate medical attention through its free online Symptom Checker and equips 1,900+ provider organizations with clinical tools that streamline workflows and support better diagnoses and health outcomes. Trained on medical data, Ubie's marketing solutions power advanced targeting capabilities and high-performing digital campaigns for 70% of the world's top life science companies.

Learn more about our vision and work at https://ubiehealth.com/company or try our free Symptom Checker at https://ubiehealth.com/.

Contact: Ryosei Hatakeyama
Ubie, Inc.
Email: pr@ubiehealth.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ubie-and-cmi-media-group-partner-to-modernize-dtc-advertising-with-highly-personalized-consumer-campaigns-in-womens-health-hematology-302453967.html

SOURCE Ubie, Inc.

FAQ

What is the partnership between Ubie and WPP's CMI Media Group about?

The partnership combines Ubie's AI Symptom Checker with CMI's media expertise to transform DTC advertising in healthcare, focusing initially on women's health and hematology/oncology to deliver personalized healthcare information to patients.

How will this partnership benefit healthcare consumers?

It will provide consumers with trustworthy, personalized healthcare information through an AI-powered symptom checker, helping them navigate their diagnosis and treatment journey while reducing confusion from unreliable online health information.

What specific healthcare areas will the Ubie-CMI partnership focus on first?

The partnership will initially focus on endometriosis (women's health) and hematology, which are high-need therapeutic areas where patients actively seek information.

What technology does Ubie use in this healthcare partnership?

Ubie uses a medically-validated AI symptom checker platform that analyzes symptom patterns to provide personalized health information and guide patients toward appropriate medical care.
Wpp Plc

NYSE:WPP

WPP Rankings

WPP Latest News

WPP Stock Data

8.44B
215.76M
10.48%
0.18%
Advertising Agencies
Communication Services
Link
United Kingdom
London